Daniel T. Scavilla has a notable investment in Globus Medical, reflecting his commitment to the company. In 2022, his vested stock options were valued at approximately $2.4 million, a significant boost from prior years as he transitioned into his current...

Daniel T. Scavilla has a notable investment in Globus Medical, reflecting his commitment to the company. In 2022, his vested stock options were valued at approximately $2.4 million, a significant boost from prior years as he transitioned into his current leadership role. Scavilla’s wealth in the company's stock indicates strong confidence in its future and aligns his interests with those of other investors. The fluctuations in his holdings highlight his focus on driving the company's performance and creating value for shareholders. As he leads Globus Medical, his commitment to the company is evident through his substantial share ownership, particularly during his rise to the CEO position in 2022. In previous years, the value of his holdings has varied with stock performance, but his recent options vesting marks a strong period for him personally and for the company overall.